Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

BIOMARKER:

EML4-NTRK3 fusion

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Entrez ID:

Related biomarkers:

‹

EML4-ALK variant 3 + TP53 mutation (5)

EML4-ALK fusion + ALK F1174L + ALK S1189C (3)

EML4-ALK fusion + ALK positive (3)

IDH1 mutation + Chr del(1p) + Chr del(19q) + NTRK3 fusion (2)

IDH1 mutation + NTRK3 fusion (2)

IDH2 mutation + Chr del(1p) + Chr del(19q) + NTRK3 fusion (2)

IDH2 mutation + NTRK3 fusion (2)

EML4-ALK + ALK G1202R + LIPI-NTRK1 (2)

EML4-ALK fusion + ALK G1202R (2)

EML4-ALK fusion + ALK rearrangement (2)

EML4-ALK fusion + TP53 mutation (2)

EML4-ALK gene fusion + EGFR exon 19 deletion + EGFR T790M + EGFR C797G (2)

MSI-H/dMMR + NTRK3 fusion (1)

NTRK3 mutation + TMB-H (1)

ALK fusion + EML4-ALK variant 3 + TP53 mutation (1)

ALK positive + EML4-ALK fusion + TP53 mutation (1)

ALK rearrangement + EML4-ALK fusion + CCDC148-ALK fusion + PKDCC-ALK fusion + VIT-ALK fusion (1)

ALK-EML4_V3a + PD-L1 overexpression (1)

ALK-EML4_V3b + PD-L1 overexpression (1)

EML4-ALK fusion + ALK I1171N (1)

EML4-ALK fusion + ALK I1171T (1)

EML4-ALK fusion + NFKBIA amplification + NKX2-1 amplification (1)

EML4-ALK fusion + TMB-L (1)

EML4-ALK fusion v1insLTBP1 (1)

STRN-ALK fusion + EML4-ALK fusion + EGFR T790M (1)

EML4-ALK variant 3 + TP53 mutation (5)

EML4-ALK fusion + ALK F1174L + ALK S1189C (3)

EML4-ALK fusion + ALK positive (3)

IDH1 mutation + Chr del(1p) + Chr del(19q) + NTRK3 fusion (2)

IDH1 mutation + NTRK3 fusion (2)

IDH2 mutation + Chr del(1p) + Chr del(19q) + NTRK3 fusion (2)

IDH2 mutation + NTRK3 fusion (2)

EML4-ALK + ALK G1202R + LIPI-NTRK1 (2)

EML4-ALK fusion + ALK G1202R (2)

EML4-ALK fusion + ALK rearrangement (2)

EML4-ALK fusion + TP53 mutation (2)

EML4-ALK gene fusion + EGFR exon 19 deletion + EGFR T790M + EGFR C797G (2)

MSI-H/dMMR + NTRK3 fusion (1)

NTRK3 mutation + TMB-H (1)

ALK fusion + EML4-ALK variant 3 + TP53 mutation (1)

ALK positive + EML4-ALK fusion + TP53 mutation (1)

ALK rearrangement + EML4-ALK fusion + CCDC148-ALK fusion + PKDCC-ALK fusion + VIT-ALK fusion (1)

ALK-EML4_V3a + PD-L1 overexpression (1)

ALK-EML4_V3b + PD-L1 overexpression (1)

EML4-ALK fusion + ALK I1171N (1)

EML4-ALK fusion + ALK I1171T (1)

EML4-ALK fusion + NFKBIA amplification + NKX2-1 amplification (1)

EML4-ALK fusion + TMB-L (1)

EML4-ALK fusion v1insLTBP1 (1)

STRN-ALK fusion + EML4-ALK fusion + EGFR T790M (1)

›

EML4-NTRK3 fusion	Solid Tumor	EML4-NTRK3 fusion	Solid Tumor	entrectinib Sensitive: C3 – Early Trials entrectinib Sensitive : C3	entrectinib Sensitive: C3 – Early Trials entrectinib Sensitive : C3
EML4-NTRK3 fusion	Lung Adenocarcinoma	EML4-NTRK3 fusion	Lung Adenocarcinoma	entrectinib Sensitive: C4 – Case Studies entrectinib Sensitive : C4	entrectinib Sensitive: C4 – Case Studies entrectinib Sensitive : C4